Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Honghui Capital is a private equity firm that provides primarily growth capital to companies in China.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
3/2022 | Artivila Therapeutics | Seed Round | 0 |
10/2020 | Zylox | Series C | 0 |
4/2021 | XINGYUN GROUP | Series C | 0 |
3/2021 | Secre Coffee | Series A | 2M |
9/2022 | Hanhua Semiconductor | Series B | - |
9/2014 | Quyi Network | Series A | 0 |
7/2021 | Eighteeth | Series A | - |
3/2021 | Thousand Oaks Biopharmaceuticals | Series C | 61.5M |
1/2022 | Tongxin Medical Equipment | Series D | 100M |
7/2018 | Shanghai Chongfu Pet Products Co. | Series A | 26.4M |
3/2022 | Artivila Therapeutics | Seed Round | 0 |
1/2022 | Tongxin Medical Equipment | Series D | 0 |
7/2021 | Eighteeth | Series A | - |
4/2021 | XINGYUN GROUP | Series C | 0 |
3/2021 | Thousand Oaks Biopharmaceuticals | Series C | 0 |
3/2021 | Secre Coffee | Series A | 0 |
10/2020 | Zylox | Series C | 0 |
7/2018 | Shanghai Chongfu Pet Products Co. | Series A | 0 |
9/2014 | Quyi Network | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|